There was a consensus that more data are needed to answer this question, with discussions about what such a trial would look ...

Patients already had high NT-proBNP levels at baseline, though, raising questions about the quality of GDMT, Nancy Sweitzer ...

"TEER may help address this gap by providing a feasible, evidence-supported option that is associated with better outcomes in this vulnerable population." Outcomes were also determined by the degree ...